Multifractal Fluctuations in Electrogram Dynamics Distinguish Atrial Fibrillation Phenotype, Drug Response, and Imminent Termination: Implications for Mechanism and Treatment
Preprint
Abstract
Structured Background: Atrial fibrillation (AF) is maintained by complex dynamics, clinically characterised by bursting periods of organization and disorganization in intracardiac electrograms. We have previously postulated that cardiac conduction behaves like a critical system, where phase shift from organised rhythm to AF is a phase transition at the critical point. We thus hypothesized that using multifractal analysis of AF electrograms could potentially quantify non-stationary fluctuations, revealing novel mechanistic insights into the cardiac critical system and examine potential clinically relevant markers of AF dynamics, phenotype and treatment response. Objectives: To determine whether multifractal analysis of AF electrograms can (i) Distinguish paroxysmal (PAF0 and non-paroxysmal AF (NPAF), (ii) predict response to pharmacologic modulation, and (iii) identify imminent spontaneous termination, thereby acting as marker of proximity to criticality along complex system phase spectrum. Methods: We analysed >1.4 million seconds of high-density bipolar electrograms from 106 patients (paroxysmal n≈52, non-paroxysmal n≈54) undergoing left atrial mapping with a 24-bipole HD-Grid catheter at standardized sites (RENEWAL AF-ANZCTR ACTRN12619001172190)). Multifractal analysis using the Wavelet Transform Modulus Maxima Method (WTMM) was applied to a burst-energy observable to derive log-normal multifractal parameters c₀ (support dimension), c₁ (spectrum location), and c₂ (fluctuations). Hierarchical mixed-effects models accounted for channels nested within locations within patients. A flecainide sub-study (n=15) provided paired pre-/post-infusion recordings, and 27 spontaneous termination events in 15 patients were analysed using 60-s pre-termination windows. Spatial texture of c₂ was quantified by variogram-derived correlation length and sill. Results: AF electrograms exhibited robust multifractality confirming multifractal fluctuations as an intrinsic property of AF. Non-paroxysmal AF showed significantly reduced fluctuations versus paroxysmal AF (c₂: β=–0.01, p=0.001), indicating a paradoxical loss of fluctuations with disease progression. Flecainide selectively increased fluctuations in paroxysmal AF (Δc₂ = +0.04, p<0.01; Δc₀ = +0.06, p<0.01) but had no significant effect on fluctuations (c2) in non-paroxysmal AF, revealing phenotype-dependent drug response. Immediately prior to spontaneous AF termination, fluctuations increased significantly compared with sustained AF (c₂: 0.198 vs 0.181, p=0.024). Spatial variogram analysis revealed heterogenous patterns in paroxysmal AF, whereas non-paroxysmal AF displayed a homogenised, flattened fluctuations landscape. Conclusions: Atrial fibrillation exhibits robust multifractal dynamics rather than random electrical activity. Reduced fluctuations characterizes non-paroxysmal AF, whereas higher fluctuations is observed in paroxysmal AF, during flecainide modulation, and immediately prior to spontaneous termination. These findings suggest that multifractal fluctuations (c₂) reflects the dynamical state of AF and may serve as a quantitative biomarker of disease progression, pharmacologic responsiveness, and proximity to termination. CONDENSED ABSTRACTT: Atrial fibrillation (AF) exhibits multifractal electrogram fluctuations that vary with disease stage, pharmacologic responsiveness, and proximity to spontaneous termination. In this study, multifractal fluctuations (c₂) was higher in paroxysmal than non-paroxysmal AF, increased selectively with flecainide in paroxysmal AF, and rose immediately before spontaneous termination. These findings identify c₂ as a quantitative marker of AF progression, and imminent reorganization. Clinically, multifractal analysis may enhance intra-procedural assessment of AF phenotype, guide drug selection, and improve recognition of transitions toward sinus rhythm, and connects AF with concepts of criticality and phase transitions.Keywords
Funding Information
- National Health and Medical Research Council (GNT2010522)
This publication has 17 references indexed in Scilit:
- 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)European Heart Journal, 2024
- 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial FibrillationJACC, 2023
- Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial FibrillationNew England Journal of Medicine, 2023
- Self-Similar Synchronization of Calcium and Membrane Potential Transitions During Action Potential Cycles Predict Heart Rate Across SpeciesJACC: Clinical Electrophysiology, 2021
- Critical slowing down as a biomarker for seizure susceptibilityNature Communications, 2020
- Electromechanical vortex filaments during cardiac fibrillationNature, 2018
- Approaches to Catheter Ablation for Persistent Atrial FibrillationNew England Journal of Medicine, 2015
- A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrateJACC, 2004
- Fractal dynamics in physiology: Alterations with disease and agingProceedings of the National Academy of Sciences, 2002
- Multifractality in human heartbeat dynamicsNature, 1999